Oncobiologics, Inc. IPO Research Information

Oncobiologics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Oncobiologics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Oncobiologics, Inc.	ONS - NASDAQ	$6.00-$6.00	$6.00	$5.12	5.8 million	5/13/2016
Underwriter(s): Jefferies, Barclays
Co-Manager(s): Cantor Fitzgerald & Co.
Industry: Health Care
Filing(s): Filed 2016-01-15 Terms Added 2016-04-27 Updated Prospectus 2016-05-11

Oncobiologics, Inc. Quote & Chart - Click for current quote - ONS

About Oncobiologics, Inc. (adapted from Oncobiologics, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ONS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.